Irene CACCIOLA

Professore associato

University of Messina

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Irene Cacciola is an Associate Professor at the University of Messina, Italy. Her research focuses on hepatic metabolic diseases, inflammatory bowel disease, colorectal cancer, and chronic hepatitis B and D. She has contributed to studies evaluating the impact of microbiota on disease progression and investigating the implications of treatment in various patient cohorts.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Filomena Morisco

University of Naples Federico II

ITALY

View details

Vincenza Calvaruso

University of Palermo

ITALY

View details

Gaetano Bertino

Associate Professor of Gastroenterology

University of Catania

ITALY

View details

Filomena Morisco

ITALY

View details

bruno cacopardo

University of Catania

ITALY

View details

Lydia Giannitrapani

University of Palermo

ITALY

View details

Fabiola De Luca

University of Messina

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Irene CACCIOLA

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression

Investigating the Impact of <i>Fusobacterium nucleatum</i> on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial

Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry

Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies

Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B

Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy

A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial

High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes

Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients

Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings

Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance

Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know?

Liver and Cardiovascular Mortality After Hepatitis C Virus Eradication by DAA: data from RESIST-HCV Cohort.

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

Outcome of cutaneous psoriasis in hepatitis C virus‐infected patients treated with Direct‐Acting Antiviral therapy

Collaborators (7)

Filomena Morisco

Vincenza Calvaruso

Gaetano Bertino

Filomena Morisco

bruno cacopardo

Lydia Giannitrapani

Fabiola De Luca

Make your next move.